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Abstract
Purpose Composite mesh prostheses incorporate proper-
ties of multiple materials for use in open ventral hernia
repair (OVHR). This study examines clinical outcomes in
patients who underwent OVHR with a polypropylene/
expanded polytetrafluoroethylene (ePTFE) composite graft
containing a novel polydioxanone (PDO) absorbable ring
to facilitate placement and graft positioning.
Methods Data were prospectively collected on consecu-
tive patients undergoing OVHR using a synthetic com-
posite mesh. Seven centers enrolled patients during the
study period. All patients underwent a standardized surgi-
cal procedure consisting of OVHR with sublay intraperi-
toneal placement of mesh. Mesh fixation was accomplished
with peripheral tacks and transfascial sutures.
Results One hundred and nineteen patients underwent
OVHR with the composite mesh. Average age was
55.8 years; there were 71 (59.7 %) females and 48
(40.3 %) males with mean BMI of 33.5 ± 7.1 kg/m2. One
hundred and two (85.7 %) patients presented with primary
ventral hernias. Mean defect size was 13.6 cm2, and mean
mesh size was 113.6 cm2. Most patients (67 %) were dis-
charged the day of surgery. Twelve patients (10.1 %)
experienced complications in the perioperative time period
primarily consisting of seroma (4.2 %) and ileus (1.7 %).
Two patients required reoperation and mesh removal in the
early postoperative period for infection and herniorrhaphy
site pain, respectively. There was a decline in pain and
movement limitation scores between baseline and 1-year
follow-up. Six-month (n = 109) and twelve-month
(n = 99) follow-up revealed no hernia recurrences (95 %
CI 0–3 %, and 0–4 %, respectively).
Conclusions The use of this second-generation composite
mesh was associated with no hernia recurrences and a low
complication rate after open ventral hernia repair.
Keywords Ventral hernia repair  Composite mesh 
Outcomes
Introduction
Ventral hernias are commonly encountered by surgeons
with an incidence of up to 20 % following laparotomy [1–
3]. Surgical decision-making for the repair of ventral and
incisional hernias includes the type and technique of repair
to be performed and if prosthetic mesh material is to be
used, what type of material is best suited in order to pro-
vide the most optimal repair. While the use of mesh for
abdominal wall reconstruction has significantly reduced
E. M. Hanna  J. F. Byrd  D. A. Iannitti (&)
Department of General Surgery, Division of Hepato-Pancreato-
Biliary Surgery, Carolinas Medical Center, 1025 Moorehead
Medical Drive, Suite 300, Charlotte, NC 28204, USA
e-mail: David.Iannitti@carolinashealthcare.org
M. Moskowitz
Gaston Memorial Hospital, Gastonia, NC, USA
J. W. F. Mann
Medical Park Hospital, Winston-Salem, NC, USA
K. T. Stockamp
Sacred Heart Health System, Pensacola, FL, USA
G. N. Patel
St. Francis Medical Center, Peoria, IL, USA
M. A. Beneke
Sutter General Hospital, Sacramento, CA, USA
K. Millikan




hernia recurrence as compared to primary repair [4–6],
there is no consensus as to which mesh provides the best
possible repair. As a result, a tremendous amount of
research has gone into the development of new and dif-
ferent prosthetic grafts for use in ventral hernia repair, with
each new innovation attempting to reduce detriments seen
with its predecessor.
In this study, we performed a post-market assessment of
the clinical and procedural outcomes of open ventral hernia
repair performed using a second-generation composite
graft. The primary endpoint was the evaluation of hernia
recurrence with secondary endpoints including periopera-
tive, short-term and long-term complications, changes in
quality of life as assessed by the Carolinas Comfort Scale
survey [7], and procedure time.
Methods
Institutional Review Board approval was obtained and data
were prospectively collected on consecutive patients
undergoing open ventral hernia repair using the VentrioTM
Hernia Patch (C.R. Bard; Davol Inc. Warwick, RI). Seven
sites contributed to patient accrual: Carolinas Medical
Center, Charlotte, NC; Gaston Memorial Hospital, Gastonia,
NC; Medical Park Hospital, Winston-Salem, NC; Sacred
Heart Health System, Pensacola, FL; St. Francis Medical
Center, Peoria, IL; Sutter General Hospital, Sacramento,
CA; and Rush University Medical Center, Chicago, IL.
Inclusion criteria were the following: age C18 years, ability
to undergo study procedure and provide informed consent,
and presence of a ventral hernia requiring open surgical
repair. Exclusion criteria included participation in another
drug or device study, life expectancy \2 years, clinical
symptoms of infected hernia site, or evidence of contami-
nated or clean contaminated fields. Demographic, operative,
perioperative, and postoperative data for each patient were
collected at each participating institution.
Adverse events in this study were defined as any
undesirable clinical event occurring in the abdominal wall,
involving abdominal organs, or judged to be related to the
surgical procedure or the VentrioTM Hernia Patch. Adverse
events were further divided according to their relationship
to the device or surgical procedure performed with sub-
categories defined as definitely, possible or not related to
the device or procedure. Relationship of the adverse event
to the device or surgical procedure was determined by the
operating surgeon in regard to their respective patients.
Adverse events were also classified by the intensity expe-
rienced by the subject as mild, moderate, or severe. Mild
events included awareness of a sign or symptom that does
not interfere with the subject’s activity and is resolved
without treatment or sequelae. Moderate events may
interfere with the subject’s activity and require additional
treatment or intervention while severe events definitely
cause significant discomfort to the subject and require
additional treatment with additional sequelae.
Perioperative adverse events occurred within 14 days of
the hernia repair. Early postoperative events occurred
between 15 days and 6 months following surgery, and late
postoperative events occurred greater than 6 months after
hernia repair.
Patient follow-up was reported at postoperative visits on
the following time points: 2 weeks, 6 months, and 1 year
with defined days during which patients were to report for
each of the follow-up visits. At each office visit, an interim
history and physical exam were performed by the operating
surgeon or a designated assistant. At each postoperative
visit and at the initial preoperative evaluation and screening,
patients were given a copy of the Carolinas Comfort Scale
(CCS) to assess quality of life characteristics related to their
hernia and postoperatively following hernia repair with
mesh. Specifically, the CCS survey evaluates quality of life
in three areas: pain, sensation of mesh, and movement
limitation during various activities. In addition, patients
were assessed at each postoperative visit via short ques-
tionnaire for time to return to normal activities of daily
living, time to return to strenuous or vigorous activity, and if
working, their ability to return to work. If at any time, a
patient was suspected by the operating surgeon to have a
recurrent hernia or to undergo imaging and a recurrent
hernia visualized, the investigator was to report the findings
immediately to the study coordinator.
Descriptive statistics were used to calculate quantitative
data including mean values, standard deviations, and pro-
portions. Frequency and proportion tables were used to
summarize the qualitative data. Defect size was calculated
by area of an ellipse: p 9 (Length/2 9 Width/2). For
analysis of results of Carolinas Comfort Scale assessment,
descriptive statistics were used to calculate mean values
with 95 % confidence intervals generated to analyze sig-
nificance of the mean. CCS questionnaires were scored with
the following parameters: if more than two questions were
left unanswered on any questionnaire (except sensation of
mesh scale at the baseline visit), the whole questionnaire
was not used in analysis. If less than or equal to two
questions were missing within any of the three scales, the
missing values were replaced by the mean of the remaining
items of the scale. Scores were assigned numerical values
corresponding to patient responses; for example, no symp-
toms were assigned score of 0 and disabling symptoms were
assigned a score of 5. Mean scores and changes from
baseline over all patients were calculated for each question.
Mean of the mean values for sensation of mesh, pain, and
movement limitation scales were calculated. No baseline
scores were reported for sensation of mesh.
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Operative procedure
The standard technique used for this surgical repair was
discussed by the participating surgeons and agreed upon
prior to beginning the study. This technique involved an
abdominal incision made overlying the area of the hernia
defect. Dissection was performed to the hernia sac which
was carefully inspected to evaluate for incarceration. The
hernia sac was opened and the peritoneal cavity entered.
If the hernia sac was to be used for graft coverage, it
was not resected. Dissection of the surrounding subcu-
taneous tissues was minimized. Adhesions were taken
down from the undersurface of the abdominal wall.
Defect size was measured as the greatest width from
edge to edge. An inspection for multiple hernia defects
was performed with measurements of all defect sizes
recorded for study purposes. Surgeons were instructed to
clear a plane of at least 5 cm around the total defect
perimeter. An appropriately sized VentrioTM Hernia
Patch was determined by the measurement of the defect
size with an additional minimum of 3 cm of overlap in
all directions. The mesh was then placed through the
fascial defect and centered on the defect from behind to
ensure a wide overlap.
A hernia mesh tacker was then used to tack the
periphery of the mesh to the abdominal wall to facilitate
fixation and stabilization of the mesh for easier placement
of transfascial sutures. The technique of tacking the mesh
involved placing the tacker through the slit in the center
of the anterior layer of the polypropylene mesh surface.
The tacker was then advanced laterally to the periphery
of the mesh while the assistant was retracting the
abdominal wall medially. The tacker was used to tack the
graft at 1- to 2-cm intervals to the abdominal wall, cir-
cumferentially. After placing the tacks, sutures were
placed through the anterior layer of mesh and through the
posterior abdominal wall in a transfascial fashion for
additional fixation. The number of transfascial sutures
placed varied with the size of the defect, although sutures
were generally placed in each of the four quadrants and
every 2–3 cm apart. When feasible, the fascia was closed
overlying the graft to achieve soft-tissue coverage over
the mesh. Finally, the abdominal incision was closed, and
drains were selectively placed at the discretion of the
operating surgeon.
For each patient, one VentrioTM Hernia Patch was used
to cover all hernia defects with adequate overlap
according to the operating surgeon. For multiple defects, a
total defect size was calculated to determine the size of
mesh utilized for repair. In patients with recurrent hernia
and prior mesh repair, the previous mesh was left in place
and the new mesh placed in a sublay position to the old
mesh.
Results
A total of 120 patients were consented in the study. One
patient elected to withdraw from the study after consent
was obtained but prior to undergoing surgery for a final
enrollment of 119 patients who underwent open ventral
hernia repair with the VentrioTM Hernia Patch. No patients
underwent concomitant procedures. All patients received
prophylactic antibiotics at the time of surgery. Follow-up
data were collected from 109 patients (92 %) at 6 months
and 99 patients (83 %) at 1 year following surgery. The
average age was 55.8 ± 13.6 years, and 59.7 % of patients
were female and 40.3 % of patients were male. Most
patients underwent open ventral hernia repair on an out-
patient basis or were discharged within 24 h of surgery.
Medical history was significant for prior abdominal sur-
geries in 78.2 % of patients, 22.7 % were current smokers,
and 21.0 % had diabetes. Table 1 lists patient demo-
graphics and operative details. In this series, 102 patients
(85.7 %) presented with primary ventral hernias and 17
patients (14.3 %) had recurrent hernias with a range of 1–4
previous repairs. Of the patients presenting with recurrent
hernias, 10 patients had prior mesh repairs (Table 2).
Table 1 Patient characteristics and operative details
Variable Mean SD Median Minimum Maximum
Age (years) 55.8 13.6 57 26 89
BMI (kg/m2) 33.5 7.1 32.9 21 51.5
Fascial defect size
(cm2)
13.6 11.1 9.4 0.8 56.5
Mesh size (cm2) 113.6 52.7 121.0 45.4 192.9
Operative time
(min)
42.8 19.8 40 11 130
Incision length
(cm)
7.5 2.7 7.0 3.0 15.0
Length of stay
(days)
0.7 1.5 0.0 0.0 11.0
Table 2 Primary and recurrent hernia repairs performed in 119
patients







Previous mesh repair 10 8.4
No previous mesh repair 7 5.9
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The VentrioTM Hernia Patch was used during all sur-
geries and secured to provide adequate overlap at the
periphery of each fascial defect; minimum mesh overlap
was defined by the study criteria as not less than 3 cm. All
surgeons utilized the previously described surgical tech-
nique for graft placement and fixation. For this series, the
average incision length was 7.5 ± 2.7 cm. The composite
mesh is commercially available in a range of sizes in both
circular and oval shapes. During the enrollment period, five
sizes were available with the largest size being the large
oval. Twenty-two patients in this series were identified to
have multiple defects for a total of 148 defects repaired in
all 119 patients enrolled. The mean fascial defect size was
13.6 ± 11.1 cm2 (median defect size 9.4 cm2, range
0.8–56.5 cm2). While a variety of graft sizes were used in
this study, the mesh size most frequently used was medium
oval (n = 40) followed by large oval (n = 28). The least
frequently used was large circle (n = 9). Only one mesh
was used in each patient including patients with multiple
defects. The majority of patients with multiple defects
presented with a primary hernia (90.9 %), only two
patients had recurrent hernia and multiple defects. The
average operative time was 42.8 ± 19.8 min. Eight
patients had drains placed at the discretion of the surgeon.
In the majority of patients, meshes were fixed at the
perimeter with an absorbable or permanent mechanical
tack fixation device. In addition, the mesh was fixed in the
center with transfascial sutures 3 cm apart using either
absorbable or permanent sutures (Table 3). The fascia was
re-approximated at the midline for mesh coverage in
65.5 % of patients. The remaining patients underwent
midline closure using either hernia sac, muscle, subcuta-
neous tissue or a combination of components.
During the study period, there were 20 patients for
which 1-year follow-up could not be obtained. There was
one patient death that occurred at approximately 6 months
following surgery. The patient had a known recurrent
metastatic pancreatic neuroendocrine tumor and expired at
an outlying facility. The cause of death was due to multi-
system organ failure and not related to the study procedure
or device. Twelve patients were lost to follow-up. Four
patients moved to a non-study participating location or
were unable to complete the study for other non-study
related conditions, and two patients withdrew from the
study following a complication and did not wish to comply
with follow-up requirements. One patient did not complete
follow-up due to an investigator and patient decision to
remove the device after continued herniorrhaphy site pain.
Table 4 lists patient complications by varying postop-
erative time periods. Twelve patients experienced 13
complications in the perioperative period, which includes
0–14 days postoperatively. The majority of these were
mild with seroma and postoperative ileus being the most
frequent. One patient complained of significant hernior-
rhaphy site pain, as noted earlier, which began postopera-
tively and extended through multiple follow-up visits. At
6-month follow-up, the patient continued to have suture
site pain and requested to have the mesh removed with
primary closure of the defect. Following mesh removal, the
patient’s pain resolved; the primary cause of pain was
Table 3 Method of mesh fixation used in 119 patients
Fixation method n %
Perimeter fixation Mechanical 113 95.0
Suture 3 2.5
Not done 3 2.5
Off-center fixation Mechanical 4 3.4
Suture 115 96.6
Not done 0 0.0
Method of midline closure Fascia 78 65.5
Hernia sac 35 29.4
Othera 6 5.0
a Either combination of fascia and hernia sac, subcutaneous tissue, or
muscle closed at midline














(non-mesh infection) 1 (\1 %) 0 0
Wound/mesh
infection
0 1 (\1 %) 0




1 (\1 %) 0 0
Hernia recurrence 0 0 0
Minor complications
Seroma 5 (4.2 %) 1 (\1 %) 0
Hematoma 1 (\1 %)
Urinary retention 1 (\1 %) 0 0
Hypoesthesia at
right thigh
1 (\1 %) 0 0
Ileus 2 (1.7 %) 0 0
Abdominal wall
erythema
0 1 (\1 %) 0
Application site
blister
1 (\1 %) 0 0
a Perioperative complications occurred up to 14 days after surgery
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likely related to a transfascial fixation suture near the costal
margin. While this patient was not seen back for 1-year
follow-up, the patient had not (as of the postoperative visit
following mesh removal) developed a recurrent hernia.
One patient developed a superficial wound infection which
was treated with antibiotics and resolved.
There were 5 complications that occurred in 4 patients
in the early postoperative period ranging from 2 weeks to
6 months after surgery. One patient developed an infected
seroma 3 months postoperatively requiring operative
drainage. At that time, the mesh was removed as it was in
the field of an infected fluid collection. One patient
developed an intraabdominal abscess, which was treated
with antibiotics and resolved. There were no late compli-
cations that occurred in patients between 6 and 12 months
after surgery. In total, 99 patients were seen in 1-year
follow-up. All patients underwent physical exam which did
not detect any evidence of hernia recurrences (95 % CI
0–4 %).
Of the recorded adverse events, investigating surgeons
implicated the mesh as possibly or definitely related to the
mesh in three instances. One patient who developed a
postoperative hematoma at the surgical site was felt to
possibly be related to the device and definitely related to
the procedure. A second patient with postoperative seroma
was definitely felt to be related to both the device and the
procedure and hernia repair site pain which was felt to be
possibly related to the surgical procedure. A third patient
with transitory erythema of the abdominal wall was defi-
nitely felt to be related to both the device and the proce-
dure. The remainder of the adverse events was felt to be
related to the procedure or not related to either the mesh or
the procedure.
Carolinas Comfort Scale surveys were satisfactorily
completed (with fewer than 2 missing questions) for
inclusion in the study by 111 by patients at the initial
preoperative visit, by 116 patients at the first 2-week
postoperative visit, by 108 patients at the 6-month post-
operative visit, and by 98 patients at 1 year following
hernia repair. Results of patient reported symptoms for
each activity in the areas of mesh sensation, pain, and
movement limitation are indicated in Table 5. Reflective in
Fig. 1 is the change in mean pain, sensation of mesh, and
movement limitation scores which all declined over the
1-year time period. By 4 weeks postoperatively, 87.8 % of
patients had returned to normal daily activity. By 7 weeks
time, 72.4 % had returned to strenuous or vigorous activity.
Of those patients working, by 4 weeks, 86.0 % were able
to return to work. Summarized in Table 6 are times to
return to work and activity for 98 patients who completed
this portion of the questionnaire at a single postoperative
visit.
Discussion
The invention of many new synthetic materials has allowed
for different types of prosthetic grafts to be used in hernia
repair. In the 1950s, polypropylene mesh was first devel-
oped by Dr. Francis Usher. Its use in hernia repair was
found to be associated with low hernia recurrence rate.
This design was modified into a knitted construct in the
1960s which has served as the basis for most prosthetic
meshes in the twentieth century [8]. Original polypropyl-
ene meshes consisting of dense ‘‘heavyweight’’ material
were occasionally associated with significant inflammatory
reactions eventually leading to mesh shrinkage and loss of
abdominal wall compliance [9]. Newer generation ‘‘light-
weight’’ polypropylene mesh caused decreased inflamma-
tory reaction leading to improved abdominal wall
compliance while still providing adequate tissue ingrowth
[10, 11].
Polypropylene mesh, however, may not represent the
most ideal mesh for intraperitoneal placement. While
short-term follow-up studies have demonstrated the safety
of polypropylene mesh when adjacent to bowel [12],
multiple studies and case reports have described concern-
ing problems when polypropylene mesh is placed intra-
peritoneal or adjacent to bowel. Reported findings include
intense intraabdominal adhesion formation, intestinal ero-
sions, and enterocutaneous fistulas [13–17].
The response to associated problems seen with poly-
propylene mesh was the creation of a combination of
materials designed to meet the varying challenges of
intraabdominal placement against different surfaces, vis-
ceral, and parietal. Composite mesh prostheses contain
Table 5 Mean Carolinas Comfort Scale Scores with change
Baseline 2 weeks 6 months 1 year Mean D baseline to 1 year
N 111 116 108 99 N/A
Pain 1.3 1.6 0.3 0.2 1.1
Sensation of mesh N/A 0.7 0.3 0.1 0.6
Movement limitation 1.1 1.4 0.2 0.1 1.0
N = number of patient questionnaires and scores used to calculate values at each of the interval time periods
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both macroporous, for example, polypropylene, and
microporous, for example, expanded polytetrafluoroethyl-
ene (ePTFE), components or absorbable barriers such as
polyethylene glycol (PEG), hyaluronic acid, and carboxy-
methylcellulose (CMC) [18]. The polypropylene material
on the parietal mesh surface causes a local inflammatory
response that promotes host tissue in-growth, while the
visceral barrier material acts to protect underlying viscera
[19, 20]. In vivo animal studies confirm the rapid tissue in-
growth obtained with composite polypropylene/ePTFE
mesh at 2 weeks (74 % of total shear strength seen at
12 weeks) [21, 22]. This combination and selective
positioning of polypropylene and ePTFE materials allows
for manipulation of the host inflammatory response to
favor rapid mesh incorporation at the parietal surface while
suppressing complications that result from contact with
abdominal viscera. Furthermore, multiple clinical studies
have demonstrated the efficacy and safety of composite
mesh materials used for ventral hernia repair [23–25].
One such composite mesh, Composix Kugel (C.R. Bard;
Davol Inc. Warick, RI), combined two layers of monofil-
ament polypropylene and a third layer of PTFE with a self-
expanding ring to aid in the placement and positioning of
the mesh intraabdominally. The Composix Kugel tech-
nique places the graft in a sublay position and does not
require the development of subcutaneous flaps. Fixation
occurs with both tacks and transfascial sutures. The results
from a large series, prospective trial examining outcomes
of this technique were published in 2008. During the 5-year
study period, this composite mesh and hernia repair tech-
nique were associated with a low rate of hernia recurrence
(1 % with an average follow-up of 29.3 months) and low
rate of early and late infection (1 and 0.4 %) [25]. Addi-
tional, small series studies have demonstrated the efficacy
and safety of this composite hernia patch using an intra-
peritoneal onlay technique in the repair of flank abdominal
bulge [26] and inguinal hernias [27].
The VentrioTM Hernia Patch (Bard Davol, Inc. Warick,
RI) was chosen for this study as it represents a composite
mesh with a memory ring. Using similar techniques of the
Composix Kugel Patch, it is a round or oval-shaped graft
that combines three layers of synthetic material with an
absorbable polydioxanone (PDO) ring that aids in posi-
tioning and intraabdominal placement (Fig. 2). The parietal
surface consists of a double layer of lightweight, large pore
polypropylene with a central opening creating a pocket to
allow for tack fixation peripherally. The visceral side is
made of ePTFE. The most novel component is an absorb-
able PDO monofilament incorporated at the periphery of
the mesh for placement and fixation. In the VentrioTM
































Pain Sensation of Mesh Movement limitations 
Fig. 1 Change in mean
Carolinas Comfort Scale scores
for pain, mesh sensation, and
movement limitations over the
course of patient follow-up
Table 6 Duration to return to physical activity
N = 98 patients who completed this portion of
questionnaire
N %
Duration to return to normal, daily activity
Less than 1 week up to 2 weeks 61 62.2
2–4 weeks 25 25.5
4–8 weeks 12 12.2
Duration to return to more vigorous or strenuous activity
Less than 3 weeks 30 30.6
3–7 weeks 41 41.8
7–11 weeks 11 11.2
More than 11 weeks 5 5.1
Not applicable 11 11.2
Duration to return to work
Less than 3 weeks 18 18.4
3–7 weeks 19 19.4
7–9 weeks 6 6.1
Not applicable 55 56.1
Patient’s physical job requirements
Minimal physical requirements 14 14.3
Moderate physical requirements 17 17.3
Heavy physical requirements 13 13.3
Not applicable/not employed 54 55.1
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Hernia Patch, this PDO ring allows the flexible mesh to
return to a flat position against the abdominal wall facili-
tating optimal positioning. Since the memory function is no
longer necessary after the mesh is secured to the abdominal
wall, the ring undergoes hydrolysis in vivo and is absorbed
[29]. In effect, this decreases the amount of foreign mate-
rial that remains in the abdomen over time.
In a preclinical study, this graft demonstrated a capacity
for strong integration of host tissues while limiting intra-
abdominal adhesion formation in a porcine model of open
ventral hernia repair. Histological evaluation showed a
progressive increase in the presence of vascular structures
following implantation. No adhesions were present in 50 %
of grafts explanted at 8 weeks. Tensiometric evaluation
revealed progressive absorption of the PDO ring after
implantation with complete mechanical degradation of the
ring by 12 weeks [28]. Full resorption of the PDO ring
material is essentially complete by 24–32 weeks.
Our study confirms findings seen similar to the VentrioTM
Hernia Patch’s progenitor of low rates of hernia recurrence
and minimal risk of infection. The low infection rate seen
likely is the result of multiple factors including surgical
technique, coverage of the mesh, small incision, and selec-
tive drain placement. While drain placement in open ventral
hernia repair has been associated with the development of
wound infections [29], neither of the patients who developed
wound infections had drains placed at the time of surgery.
Other factors in these patients including obesity, smoking,
and presence of significant medical comorbidities may have
contributed to the development of postoperative surgical site
infection. In this series, no hernia recurrences were seen in
the 1-year time period. Significant mesh overlap was noted as
mean defect size was 13.6 cm2 while mean mesh size used
for defect coverage was 113.6 cm2 which gives a ratio of
mesh coverage to defect size of 8.4 cm2.
Improved clinical outcomes have been seen with the
use of tension free mesh repair techniques in ventral
hernia repair [4, 5]. As a result, the evaluation of quality
of life prior to and following ventral hernia repair is
important in understanding the impact surgical treatment
has on the medical condition and benefit perceived by
patients. A general measurement of surgical outcomes can
be obtained with the Medical Outcomes Study 36-Item
Short-Form Health Survey (SF-36). However, prior studies
have demonstrated that disease-specific questionnaires are
more useful than general questionnaires in the evaluation
of patient symptom severity and changes caused by sur-
gical treatment [30, 31]. The Carolinas Comfort Scale
(CCS), developed at Carolinas Medical Center, is a dis-
ease-specific questionnaire that accurately reflects patient
satisfaction following hernia repair and quality of life. As
compared to the SF-36, the CCS was found to better
predict patient-perceived symptoms and satisfaction fol-
lowing hernia repair [7]. These findings were replicated in
a follow-up study in which the CCS was more sensitive
than the SF-36 in detecting change in patients’ quality of
life following laparoscopic versus open ventral hernia
repair [32].
Fig. 2 VentrioTMHernia Patch. a polypropylene surface with inter-
nalized, absorbable polydioxanone (PDO) ring (arrow), b expanded
polytetrafluoroethylene (ePTFE) surface, c fixation device placed
between the polypropylene bi-layer fixation pocket
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In this investigation, improvement in CCS scores can be
defined from the basis of an overall average improved
change in symptoms related to the patient’s ventral hernia.
At baseline, an average pain score of 1.3 correlates to mild
symptoms bothersome in some patients. This value
declined to 0.2 at the conclusion of the study period with a
value of zero corresponding to no symptoms at all. Similar
improvement was noted in patients’ mean movement lim-
itation scores which declined well beyond the baseline
prior to hernia repair. The mean change in sensation of
mesh score also improved from 2 weeks following surgery
to 1-year follow-up visits. The majority of patients in this
study had returned to normal daily activity by 4 weeks
following surgery and by 7 weeks after surgery had
resumed vigorous or strenuous activity. Statistical analysis
of pre- and postoperative CCS scores was not performed as
post hoc analyses would not be appropriate to make
inferences regarding the statistical significance of these
values. While a decline was clearly indicated in the
descriptive results of CCS scoring pre- and post-interven-
tion, a more sufficiently powered study with control group
would be required to provide an accurate comparative
analysis.
This study is strengthened by its multi-institutional
design. While a common surgical repair technique was
agreed upon and utilized in this series, slight differences in
surgical practice between surgeons and institutions are
more reflective of practicing surgeons than would be seen
in a single surgeon series. The surgeons participating in this
study are highly experienced in this type of hernia repair
technique with a large volume of clinical experience.
In summary, this study demonstrates that the use of a
second-generation composite mesh for open ventral hernia
repair results in low rate of perioperative and early com-
plications with no hernia recurrence seen in the 1-year
study period. Patients overall had excellent outcomes with
improvement in mean pain and movement limitation scores
from baseline values. Sensation of mesh scores also
improved from 2 weeks postoperative to 1-year follow-up
time points. The absorbable PDO ring assists the surgeons
with placement and fixation of the mesh but has the added
benefit of dissolving over time, decreasing the amount of
foreign material left in the body. Overall findings from this
investigation are based on an observational study design
with 83 % follow-up of patients at 1-year post-surgery.
Further studies are needed to follow-up long-term results to
confirm the low rate of hernia recurrence and additional
long-term complications with this composite mesh.
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